Eternygen

Small molecule for the treatment of metabolic diseases

placeBerlin, Berlin, Germany calendar_todayFounded 2012 groups1 employees language eternygen.de

Registered entities

Investor mix

7 investors on record; lead investors include IBB Ventures, Evotec.

Investor typeCountShare
Venture capital229%
Accelerator & incubator114%
Other / undisclosed457%
Coming soon